I recently read a blog article by Paul Offit and watched a related interview in which he expresses strong concern about Robert F. Kennedy Jr. and his actions regarding childhood vaccination. In both the article (link) and the interview (link), Kennedy is repeatedly framed as a non-medical outsider, while medical professionals are presented as unquestionable authorities on science.
However, a careful reading reveals several weaknesses and inconsistencies in Dr. Offit’s claims—particularly in how vaccine efficacy is presented and interpreted.
One example stands out. Dr. Offit cites three studies reporting vaccine efficacy ranges of approximately 52–61%, 63–78%, and 67%, respectively. He characterizes these figures as representing high-quality and strong evidence of effectiveness. From a scientific standpoint, this interpretation is problematic.
First, vaccine efficacy is inherently a relative measure, not an absolute one, which tends to inflate the outcome. Even taking these numbers at face value, two of the cited studies show maximum efficacy only in the low-to-mid 60% range, while the highest reported figure is 78%. By any rigorous standard, these are modest results—not exceptional ones—yet they are presented as decisive proof.
To illustrate the issue, consider an analogy: would anyone willingly purchase a car advertised to function properly only 52–78% of the time, especially if the manufacturer—not an independent evaluator—supplied those figures, and if the same product carried a risk of catastrophic failure? Few would accept such uncertainty for transportation, let alone for medical interventions administered to children.
More troubling is the broader scientific context. Vaccines are promoted despite the fact that the alleged causal agents—viruses—have not been conclusively identified or characterized as physical entities in a manner consistent with foundational science. Moreover, vaccines have not been tested in patients to directly establish efficacy against a confirmed causal agent of disease. Without a verified cause, claims of prevention remain speculative.
Dr. Offit further argues that objections raised by the Cochrane Collaboration are flawed because they “… ignored the many observational studies that are the single best way to determine real-world vaccine effectiveness.” This assertion is revealing. Observational studies, by definition, lack proper controls and are vulnerable to confounding variables. They dominate medical and virological research precisely because controlled experimentation is absent—not because they represent the highest scientific standard.
In reality, much of what passes for medical “evidence” in virology and vaccinology is observational rather than experimentally controlled in the strict scientific sense. Treating such studies as definitive substitutes for rigorous validation undermines the credibility of the conclusions drawn from them.
Taken together, Dr. Offit’s case for vaccine efficacy is weak. Efficacy figures below 78% and reliance on observational data do not constitute robust scientific proof—particularly when the underlying causal framework remains unverified. Under these conditions, continued promotion of vaccines, especially for children, warrants serious reconsideration.
In this respect, Kennedy’s call to reassess vaccination policy is scientifically defensible. Questioning weak evidence is not anti-science; it is science. Calls to halt, review, and critically re-evaluate vaccine use are justified when claims rest on assumptions rather than demonstrable physical reality.